Skip to main content

Talk to us: 0333 004 4488 | hello@brabners.com

Support for those affected by prolonged temozolomide chemotherapy treatments — Professor Ian Brown accused of failing patients

AuthorsFiona TinsleyBecky Addison

Prolonged chemotherapy patient doctor holding hand drip
Updated on 19 February 2025

Recent revelations have raised concerns about patients who were subjected to prolonged temozolomide (TMZ) chemotherapy treatments at the University Hospitals of Coventry and Warwickshire NHS Foundation Trust. 

These treatments were administered under the care of Professor Ian Brown “without any scientific evidence to support this practice”, according to the Trust’s Clinical Service Lead for Oncology. This has sparked an investigation into how many patients received unnecessary long-term chemotherapy and the potential harm that it may have caused.

As reported by the BBC, the Trust is "carrying out an internal review into what happened", with patients only finding out that they were taking unnecessary medication when Professor Brown "retired from being a practising doctor".

 

Background to this case

In 2024, we were instructed on behalf of a patient who was under the care of Professor Brown (and his colleague Ian Edwards) at University Hospitals Coventry & Warwickshire NHS Trust. 

Our client instructed us that they'd been informed by a Trust clinician that adjuvant temozolomide longer than twelve cycles isn’t recommended for brain tumours and there’s no scientific evidence that supports this practice. The client therefore alleged that they'd received unnecessary chemotherapy treatment for over 14 years. Throughout this time, they had to endure the cyclical adverse side effects of this chemotherapy treatment, which significantly impacted their physical and mental health, family life and work. They’re also understandably concerned about the long-term effects of taking this drug.

Fiona Tinsley and Becky Addison quickly went to work, arranging face to face meetings with this client and family affected and identifying suitable experts to provide independent opinion on the legal issues of this case as well as identifying a suitable barrister to work together as a team. We’ve extensively investigated what has been going on within this NHS Trust.

 

What's happening now?

We have now had the opportunity to speak with other patients who were also under the treatment and care of Professor Ian Brown and had also been subject to prolonged unnecessary chemotherapy. 

From these opportunities, we’re now seeing recurring themes in their care, with treatment having continued despite radiology scans showing that the tumour is stable, no signs of tumour progression or recurrence throughout. 

Many patients were told that they needed the treatment to stay alive, yet upon the hospital’s new oncology team re-examining the initial tumour histology from when patients were initially diagnosed, most of the diagnoses had significantly changed from the initial apparent grading to a lower grade and in one case showed no initial tumour at all.

For many, this revelation may come as a shock after years of believing that they were undergoing life-saving treatment.

 

22 months of unnecessary chemotherapy — Richard Walker

Richard Walker is a father of two who has bravely come forward to tell his story after reading about this case via the BBC. He thought that taking Temozolomide indefinitely “was his only option to stay alive”. 

"I feel like I've put my illness and my life into the hands of somebody you naturally trust and then, to find out I didn't necessarily need 22 months of chemo, is very shattering and confusing”, Richard told the BBC. 

In the same article, Fiona revealed that some of our clients have developed conditions like secondary cancer and liver damage that could be a result of prolonged Temozolomide treatment.

"We've got patients who've got mobility problems, long-term gastrointestinal problems”, Fiona said. “And when they queried — in particular the gastrointestinal problems — with clinicians at the Trust, they were dismissed as if it was nothing to do with the chemotherapy and not referred for investigation. They've had to seek out those investigations on their own."

 

Controversy surrounding temozolomide treatment

Temozolomide is a common chemotherapy drug used to treat certain types of brain tumours. 

Typically, the course of treatment is short-term and based on guidelines developed from national and international clinical studies. However, in this case some patients were administered chemotherapy for extended periods, lasting several years. The situation came to light after a patient whose brain tumour had been successfully removed over a decade ago continued to receive chemotherapy despite their tumour remaining stable.

With Professor Brown’s retirement in late 2023, the Trust has begun reviewing all patients with similar cases who were under his care and subjected to the same prolonged chemotherapy. According to the Trust, this approach “was not in line with national and international guidelines and standards”, which has raised questions about the necessity of such treatment.

 

Seeking justice & accountability

For patients affected by this unnecessary treatment, the journey to recovery now includes seeking justice. Our medical negligence solicitors — who specialise in such cases — are stepping in to offer support to those impacted by Professor Brown’s treatment. 

Our experience in working on these cases so far puts us in the best possible position to help you make a successful claim and start to move forward in life. We’ve developed unique insight into the decision-making processes and practices of these clinicians, as well as wider understanding from other professionals both across the Trust and outside of the Trust. 

If you’ve been affected by unnecessary and prolonged chemotherapy, be assured that we’ll react quickly and stand by your side to support you in seeking accountability, justice and financial compensation — from the very first moment you make contact with us throughout each step of the process.

If you believe that you or a loved one may have been subjected to unwarranted chemotherapy while being treated by Professor Brown, it’s essential to know your legal options. Pursuing a medical negligence claim may not only provide financial compensation but also hold medical professionals accountable for their actions.

 

How we can help

Experiencing unnecessary treatment can dramatically impact your life — from disrupting your career, personal goals and family life to causing significant financial strain. 

Our lawyers are experts in justice for families affected by medical negligence. We’re here to guide you through every step of the process, offering sensitive and thorough case analysis.

If it’s proven that Professor Brown or his colleague Ian Edwards contributed to harm through their prolonged chemotherapy regime, affected patients could be entitled to compensation for:

 

What is unnecessary chemotherapy?

Unnecessary chemotherapy occurs when a treatment continues beyond the point of medical need, offering no further benefit to the patient. 

Patients who were diagnosed with brain tumours and subjected to chemotherapy for more than one year without clear justification could be victims of unnecessary treatment. This can result in debilitating side effects and significant disruptions to daily life, including work, family responsibilities and financial stability. 

The emotional toll of learning that a challenging cancer journey could have been avoided can be overwhelming for both patients and their families. 

If you find yourself in this situation, it’s important to reach out for support.

 

Talk to us for free, no-obligation advice

We understand how difficult it can be to process the news that your treatment may have been unnecessary. We're experts in medical negligence relating to chemotherapy treatments.

Talk to us today for a free, no obligation discussion. Our experts will sensitively and confidentially explain how we can support you through this process and empower you to seek accountability, win justice, rebuild your life and recover compensation.

We're available to come and meet you wherever you're located. Give us a callsend us an email or complete our contact form below.

You can also get in touch with Fiona and Becky directly.

Becky Addison

Becky is a Paralegal in our medical negligence team.

    Read more
    Becky Addison

    Fiona Tinsley

    Fiona is a Partner in our litigation team and our head of medical negligence and serious personal injury.

      Read more
      Fiona Tinsley

      Watch: unnecessary chemotherapy & Temozolomide FAQs

      Chemo video thumbnail

      FAQs

      Talk to us

      Loading form...

      Related insights